Systemic Inflammation and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: State of the Art and Novel Insights in Regulation of Muscle Plasticity-Reference-Cited by-同舟云学术

Systemic Inflammation and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: State of the Art and Novel Insights in Regulation of Muscle Plasticity

Published:2007-09 Issue:3 Volume:28 Page:537-552
ISSN:0272-5231
Container-title:Clinics in Chest Medicine
language:en
Short-container-title:Clinics in Chest Medicine

Author:

Remels Alexander H.,Gosker Harry R.,van der Velden Jos,Langen Ramon C.,Schols Annemie M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine

Reference129 articles.

1. Systemic effects of chronic obstructive pulmonary disease;Agusti;Proc Am Thorac Soc,2005

2. Chronic obstructive pulmonary disease: effects beyond the lungs;Balasubramanian;Curr Opin Pulm Med,2006

3. Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease;Mador;Am J Respir Crit Care Med,2002

4. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives;Gosker;Am J Clin Nutr,2000

5. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance;Satta;Eur Respir J,1997

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible relationship between the gut leaky syndrome and musculoskeletal injuries: the important role of gut microbiota as indirect modulator;AIMS Public Health;2023

2. Pulmonary Rehabilitation;Airway diseases;2023

3. Diaphragm Dysfunction and Rehabilitation Strategy in Patients With Chronic Obstructive Pulmonary Disease;Frontiers in Physiology;2022-05-02

4. Role of IL-33 receptor (ST2) deletion in diaphragm contractile and mitochondrial function in the Sugen5416/hypoxia model of pulmonary hypertension;Respiratory Physiology & Neurobiology;2022-01

5. Nutrition and NSCLC; Should We Administer Food Supplements?;Current Pharmaceutical Design;2021-10-22